A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion

University of Michigan Rogel Cancer Center

Status: Completed

Conditions: Liver Cancer

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT01210027

HUM 5910 (Other Identifier)

UMCC 2006.067

Details and patient eligibility

About

Researchers at the the University of Michigan are conducting a research project to assess how a course of radiation therapy changes the way blood flows through the liver. To be able to do this, the researchers will be using MRI (magnetic resonance imaging) scans completed before, during, and after radiation therapy. MRI's will be done on 4 or 5 occasions. On each occasion, you will be injected with a fluid called gadolinium (a contrast agent) before getting an MRI. This contrast agent makes it easier for the Researchers to see your organs in the scans, and causes any abnormal areas to become very bright on the MRI. This agent will be injected into a vein in your arm or leg. Each MRI scan will last approximately 45 minutes.

Enrollment: 143 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients must be ≥18 years of age.
• The patient's planned cancer management is radiation to the liver with or without chemotherapy.
• Patients must have a performance status of 0-2 and a life expectancy of at least 3 months.
• Patients should have no contraindications to having a contrast enhanced MRI scan.

Exclusion criteria

• Women who are pregnant or breastfeeding are excluded.
• Prisoners are excluded